Abstract
Chemotherapy induces injury to tumor cells, which subsequently die by a number of processes. One of those processes is apoptosis, and its measurement can be a useful tool to understanding the mechanisms of action of chemotherapy agents, drug resistance, and tumor biology. Cells undergoing apoptosis eventually cleave their DNA with nucleases in a character istic pattern that leaves free 3′OH ends. This permits the identification of cells undergoing apop tosis by transfer of fluorescence-labeled dUTP to the free 3′OH ends using the enzyme terminal deoxynucleotidyl transferase (TdT) in a process termed terminal deoxynucleotidyl transferase dUTP-mediated nick end labeling (TUNEL). This chapter outlines the concepts governing the measurement of apoptosis following chemotherapy by TUNEL in cells in culture and in tissue biopsied from patients or laboratory animals that received chemotherapy. It lists the reagents, pro cedures for cell and tissue handling, labeling techniques, caveats, and appropriate controls for labeling 3′OH termini with TdT and quantifying the results.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
DeVita, V. T. Jr., Hellman, S., and Rosenberg, S. A. (eds.) (2001) Cancer Princi ples & Practice of Oncology. Lippincot Williams & Wilkins, Philadelphia.
Saravanan, V. and Hamilton, J. (2002) Advances in the treatment of rheumatoid arthritis: old versus new therapies. Expert Opin. Pharmacoth. 3, 845–856.
Szekeres, T. and Novotny. L. (2002) New targets and drugs in cancer chemother apy. Med. Principles Practice 11, 117–125.
Bocci, G., Nicolaou, K. C., and Kerbel, R. S. (2002) Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antian giogenic window for various chemotherapeutic drugs. Cancer Res. 62, 6938–6943.
McCrudden, K. W., Yokoi, A., Thosani, et al. (2002) Topotecan is anti-angiogenic in experimental hepatoblastoma. J. Pediatr. Surg. 37, 857–861.
Bryunet, L., Gunby, R. H., Benson, R.S., Hickman, J. A., Watson, A. J., and Brady, G. (1998) Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers. Cell Death Different. 5, 107–115.
Tannock, I. F. and Lee, C. (2001) Evidence against apoptosis as a major mecha nism for reproductive cell death following treatment of cell lines with anti-cancer drugs. Br. J. Cancer 84, 100–105.
Green, D. R. and Reed, J. (1998) Mitochondria and apoptosis. Science 281, 1309–1312.
Matsuo, A., Watanabe, A., Takahashi, T., et al. (2001) A simple method for classification of cell death by use of thin layer collagen gel for the detection of apoptosis and/or necrosis after cancer chemotherapy. Jpn. J. Cancer Res. 92, 813–819.
Kaufmann, S. H. and Earnshaw, W. (2000) Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256, 42–49.
Oyaizu, H., Adachi, Y., Taketani, S., Tokunaga, R., Fukuhara, S., and Ikehara, S. (1999) A crucial role of caspase 3 and caspase 8 in paclitaxel-induced apoptosis. Mol. Cell iol Res. Commun. 2, 36–41.
Milner, A. E., Palmer, D. H., Hodgkin, E. A., et al. (2002) Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and syn ergy with death receptor ligands in ovarian carcinoma cells. Cell Death Different. 9, 287–300.
Kerr, J. F. R., Wyllie, A. H., and Currie, A. R. (1972) Apoptosis: a basic biologi cal phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239–257.
Xiang, J., Chao, D. T., and Korsmeyer, S. J. (1996) BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93, 14,559–14,563.
Kumi-Diaka, J. (2002) Chemosensitivity of human prostate cancer cells PC3 and LNCaP to genistein isoflavone and β-lapachone. Biol. Cell 94, 37–44.
Leist, M., Single, B., Castoldi, A. F, Kiihnle, S., and Nicotera, P. (1997) Intracel lular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185, 1481–1486.
Hirsch, T., Marchetti, P., Susin, S. A., et al. (1997) The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition deter mine the mode of cell death. Oncogene 15, 1573–1581.
Wang, Q., Yang, W., Uytingco, M. S., Christakos, S., and Wieder, R. (2000) 1,25(OH)2 vitamin D3 and all-trans retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Res. 60, 2040–2048.
Kerr, J. F. R., Winterford, M., and Harmon, V. (1994) Apoptosis: its signifi cance in cancer and cancer therapy. Cancer 73, 2013–2026.
Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P., and Lipton, S. A. (1995) Apoptosis and necrosis: two distinct events induced respectively by mild and intense insults with NMDA or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA 92, 7162–7166.
Kuan, Y., Yang. D. D., Samanta Roy, D. R., Davis, R. J., Rakic, P., and Flavell, R. A. (1999) The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22, 667–676.
Kawase, Y., Takemura, G., Hayakawa, K., et al. (2002) Abundant apoptosis in nutmeg liver of cardiomyopathic hamsters. Apoptotic cell death as a possible mechanism of hepatic remodeling by congestion. Pathol. Res. Practice 198, 291–298.
Swynghedauw, B. (1999) Molecular mechanisms of myocardial remodeling. Physiolog. Rev. 79, 215–262.
Kim, R., Tanabe, K., Uchida, Y., Emi, M., Inoue, H., and Toge, T. (2002) Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy. Cancer Chemother. Pharmacol. 50, 343–352.
Kluck, R. M., Bossy-Wetzel, E., Green, D. R., and Newmeyer, D. D. (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132–1136.
Desagher, S., Osen-Sand, A., Nichols, A., et al. (1999) Bid-induced conforma tional change of Bax is responsible for mitochondrial cytochrome C release during apoptosis. J. CellBiol. 144, 891–901.
Li, P., Nijhawan, D., Budihardjo, I., et al. (1997) Cytochrome C and dATP dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479–489.
Earnshaw, W. C., Martins, L. M., and Kaufmann, S. H. (1999) Mammalian cas pases: structure, activation, substrates, and functions during apoptosis. Ann. Rev. Biochem. 68, 383–424.
Oberhammer, F., Wilson, W. W., Dive, C., et al. (1993) Apoptotic death in epithe lial cells: cleavage of DNA to 300 and/or 50 Kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12, 3679–3684.
Brown, D. G., Sun, X. M., and Cohen, G. M. (1992) Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J. Biol. Chem. 268, 3037–3039.
Huang, P., Robertson, L. E., Wright, S., and Plunkett, W. (1995) High molecular weight DNA fragmentation: a critical event in nucleotide analogue-induced apop tosis in leukaemia cells. Clin. Cancer Res. 1, 1005–1013.
Wyllie, A. H. (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284, 555–556.
Lecoeur, H. (2002) Nuclear apoptosis detection by flow cytometry: influence of endogenous endonucleases. Exp. Cell Res. 277, 1–14.
Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. (1992) Identification of pro grammed cell death in situ via specific of nuclear DNA fragmentation. J. Cell Biol. 119, 493–501.
McKenna, S. L., Hoy, T., Holmes, J. A., Whittaker, J. A., Jackson, H., and Padua, R. A. (1998) Flow cytometric apoptosis assays indicate different types of endonu clease activity in haematopoietic cells and suggest a cautionary approach to their quantitiative use. Cytometry 31, 130–136.
Jin, K., Chen, J., Nagayama, T., et al. (1999) In situ detection of neuronal DNA strand breaks using the Klenow fragment of DNA polymerase I reveals different mechanisms of neuron death after global cerebral ischemia. J. Neurochem. 72, 1204–1214.
Collins, R. J., Harmon, B, V., Gobe, G. and Kerr, J. F. (1992) Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Intl. J. Rad. Biol. 61, 451–453.
Kanoh, M., Takemura, G., Misao, J., et al. (1999) Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomy opathy. Not apoptosis but DNA repair. Circulation 99, 2757–2764.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Wieder, R. (2005). TUNEL Assay as a Measure of Chemotherapy-Induced Apoptosis. In: Blumenthal, R.D. (eds) Chemosensitivity: Volume II. Methods in Molecular Medicine™, vol 111. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-889-7:043
Download citation
DOI: https://doi.org/10.1385/1-59259-889-7:043
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-58829-586-6
Online ISBN: 978-1-59259-889-2
eBook Packages: Springer Protocols